Cancer Research Technology
Log in Register
Menu

JIM3 Cell Line

Info

Catalogue Number 151450
Host Human
Tissue Blood
Disease Keywords Human multiple myeloma, cancer
Model Tumour line
Relevance JIM3 was established from plasma myeloma cells derived from pleural fluid of an advanced multiple myeloma patient, and is homoplastic with the cell line JIM1. It allows in vitro study and comparison of genetic instability in myeloma tumour lines and in vitro study of the effects of DNA repair deficiency in myeloma tumour lines. JIM3 shows typical plasma cell phenotype (CD38, PCA-1 8A and CD24 positive), deficient in DNA repair.
Production Details Derived from plasma myeloma cells from pleural fluid of advanced multiple myeloma female patient.
Research Area Cancer, DNA Damage and Repair, Drug Discovery & Development
Recommended Growing Conditions Dexter culture medium, consisting of Fischer's medium + 20% FCS +10-7 M hydrocortisone sodium succinate. Seed at 2-9 x 10 5 cells/cm3 5% CO2; 37°C
Notes STR profiling showed that this cell line is of female origin
Cellosaurus ID CVCL_2533

References: 6 entries

Leone et al. 2008. Clin Cancer Res. 14(19):6033-41. PMID: 18829482.

Deletions of CDKN2C in multiple myeloma: biological and clinical implications.

Europe PMC ID: 18829482

Velangi et al. 2004. Carcinogenesis. 25(10):1795-803. PMID: 15142887.

DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.

Europe PMC ID: 15142887

Hamilton et al. 1991. Leukemia. 5(9):768-71. PMID: 1943229.

Normal and neoplastic human plasma cells express bcl-2 antigen.

Europe PMC ID: 1943229


Add a reference

References: 6 entries

Leone et al. 2008. Clin Cancer Res. 14(19):6033-41. PMID: 18829482.

Deletions of CDKN2C in multiple myeloma: biological and clinical implications.

Europe PMC ID: 18829482

Velangi et al. 2004. Carcinogenesis. 25(10):1795-803. PMID: 15142887.

DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.

Europe PMC ID: 15142887

Hamilton et al. 1991. Leukemia. 5(9):768-71. PMID: 1943229.

Normal and neoplastic human plasma cells express bcl-2 antigen.

Europe PMC ID: 1943229


Add a reference

References: 6 entries

Leone et al. 2008. Clin Cancer Res. 14(19):6033-41. PMID: 18829482.

Deletions of CDKN2C in multiple myeloma: biological and clinical implications.

Velangi et al. 2004. Carcinogenesis. 25(10):1795-803. PMID: 15142887.

DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.

Hamilton et al. 1991. Leukemia. 5(9):768-71. PMID: 1943229.

Normal and neoplastic human plasma cells express bcl-2 antigen.


Add a reference


This reagent does not have any reviews at the moment.